Andrew Davies

Professor of Haematological Oncology, University of Southampton

Director Southampton Cancer Research UK/ National Institutes of Health Research Experimental Cancer Medicines Centre

United Kingdom

Andrew Davies is Professor of Haematological Oncology in the Cancer Sciences Unit in the Faculty of Medicine, University Hospital Southampton. He completed his training in Medical Oncology at St Bartholomew���s Hospital in London, and as a Cancer Research UK clinical fellow he undertook a PhD examining the molecular mechanisms underlying transformation of follicular lymphoma to more aggressive histological sub-types. Prof. Davies specialises in the treatment of malignant lymphoma. He has a particular interest in the investigation of monoclonal antibody-containing therapies and other novel therapeutics applied to lymphoma. His work also focuses on translation of biomarkers and novel therapies to the clinical arena. He has extensive experience in early phase trials, including leading several first in man lymphoma studies all the way through to leading late phase studies. He is Chair of the UK National Cancer Research Institute Lymphoma Research Groups and past Chair of the High Grade Lymphoma Study Group. He is Director of the Cancer Research UK/National Institute of Health Southampton Experimental Cancer Medicine Centre. He is also the Wessex regional lead for cancers in Teenagers and Young Adults (TYA) and Clinical Lead for the Thames Valley and Wessex TYA Operational Delivery Network